CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 3/A Insider 3/A
- 3/A Insider 3/A
- 10-K Report Annual Report
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G Stake Amended Statement of Ownership
- 4 Conversion 10% owner acquired 1,690,646 shares (conversion)
- 4 Open-market buy Director bought 720,000 shares at $10.00 ($7,200,000)
- 4 Open-market buy Director bought 100,000 shares at $10.00 ($1,000,000)
- 4 Open-market buy Director bought 180,000 shares at $10.00 ($1,800,000)
- 4 Open-market buy Sr. VP, Business Dev., CBO bought 200 shares at $10.00 ($2,000)
- 4 Open-market buy Sr. VP, Research and CMO bought 300 shares at $10.00 ($3,000)
- 424B4 Offering Prospectus
Page 59 of 62 · 1,224 filings